Children's cancers, Neuroblastoma
Results
Phase 2
This trial looked at dinutuximab beta with or without interleukin-2 for neuroblastoma. And at giving treatment over a longer period of time.
It was for children and young people whose cancer had come back after treatment. Or had continued to grow while having treatment.
The trial was supported by Cancer Research UK. It was open for people to join between 2012 and 2017. The team have published several results papers between 2018 and 2025. We hope to update this page if more results become available.
Recruitment start: 1 January 2012
Recruitment end: 31 July 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Juliet Gray
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
International Society of Paediatric Oncology European Neuroblastoma (SIOPEN) Group
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/11/035.
Last reviewed: 03 Oct 2025
CRUK internal database number: 8781
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
